Cupping Therapy in Fibromyalgia

INTERVENTION: This is a two‐arm, single‐blind, randomized controlled clinical trial. Experimental group: 12 women with fibromyalgia received vetotherapy treatment for 20 minutes on the bladder meridian (dorsal Shu) bilaterally at the physical and psychic point, once a week for 6 consecutive weeks. The Sham group: 11 women received false cupping therapy for 20 minutes on the bladder meridian (dorsal Shu) bilaterally at the physical and psychic point, once a week for 6 consecutive weeks. Randomization was performed randomly by a researcher who is not part of the research. The randomization method used to generate the allocation sequence was through the website www.randomaizer.org. There was single‐blind masking. CONDITION: C05.651 Fibromyalgia PRIMARY OUTCOME: Expected outcome 1 that will be analyzed using the Numerical Pain Scale. It is expected to find a significant difference in the reduction of less than 2 scores in pain perception in the experimental group Expected outcome 2 which will be analyzed using the 2010 American College of Rheumatology scale for the diagnosis of fibromyalgia. It is expected to find significant statistical differences in the total score and subitems of the scale with a reduction in values when comparing groups and between times in the experimental group Outcome found 1 analyzed using the Numeric Pain Scale. In the study sample, we did not find a significant difference in pain reduction in the experimental group Outcome found 2 analyzed using the 2010 American College of Rheumatology scale for the diagnosis of fibromyalgia. In the subscale named generalized pain index, we found a statistically significant difference in the comparison between pre‐ and post‐intervention times SECONDARY OUTCOME: Expected outcome 3 which will be analyzed using the Fibromyalgia Impact Questionnaire. It is expected to find a significant statistical difference in the decrease in total scores and scale subitems when comparing groups and between the initial and final times in the experimental group Expected outcome 4 which will be analyzed using the Functional movement screening scale. It is expected to find a significant statistical difference in the increase in total scale scores when comparing groups and between the initial and final times in the experimental group Expected outcome 5 which will be analyzed by the flexibility test (Finger on the floor test). It is expected to find a statistically significant difference in the reduction in the values found in the test in the comparison between groups and between times for the experimental group Outcome found 3 analyzed by the Fibromyalgia Impact Questionnaire. We found a statistically significant difference within the group in the total score of the scale and in the sub‐items for the variables It interfered with your ability to do your job, Did you feel pain and Rigidity, there was a reduction in the values obtained Outcome found 4 analyzed by the Functional movement screening scale. We found no statistically significant difference either within the group or between the groups Outcome found 5 analyzed by the flexibility test (Finger on the floor test). We found no statistically significant difference either within the group or between the groups INCLUSION CRITERIA: Age between 30 and 65 years old; female and presenting the clinical diagnosis with fibromyalgia syndrome;; for more than three consecutive months; which was based on the diagnostic criteria of the American College of Rheumatology (2010); accept to participate and sign the Informed Consent Term (TCLE)